Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Central Garden & Pet (NASDAQ:CENT) and its peers.

Over the past six months, WSFS Financial has been a great trade, beating the S&P 500 by 8%. Its stock price has climbed to $65.54, representing a healthy 14.2% increase. This was partly thanks to its solid quarterly results, and the performance may have i

Futures on the major gauges dip ahead of a highly anticipated State of Union address by the president.

Oracle upgraded, Workday downgraded: Wall Street's top analyst calls

Adobe has underperformed the technology sector over the past year. However, Wall Street analysts remain moderately bullish about its prospects.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the inspection instruments industry, including Keysight (NYSE:KEYS) and its peers.

What a fantastic six months it’s been for Moderna. Shares of the company have skyrocketed 99.8%, hitting $50.65. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Applied Materials has notably outperformed the S&P 500 over the past year, and analysts are highly optimistic about the stock’s prospects.

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their

T-Mobile US has underperformed the Dow Jones Industrial Average over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.

Goldman Sachs has outperformed other capital market stocks over the past year, and analysts remain moderately optimistic about the stock’s future outlook.

American Express has outperformed the Digital Payments industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of the

Abbott Laboratories has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

While Intuitive Surgical has underperformed the Dow over the past year, analysts remain moderately bullish on its future outlook.